Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04040140 · ClinicalTrials.gov registry record · NA

Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
31
Enrollment target

NCT04040140: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT04040140 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04040140, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

The aims of this proposal are to (1) examine the feasibility of providing a training course of Auricular Point Acupressure (APA) for clinical oncology nurses who can integrate APA into real-world nursing care settings and (2) examine the effectiveness of APA on cancer-related pain (CRP) under the usual conditions.

Primary Outcome

Pain intensity in the last 24 hours (1) at its worst and (2) on average will both be measured on a scale of 0 (no pain) to 10 (pain as bad as you can imagine).

Interventions

  • OTHER APA Treatment

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2019-10-08
Est. Completion 2021-01-30
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT04040140 stopped before completion

NCT04040140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which APA Treatment is the first listed.

NCT04040140 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04040140 about?

NCT04040140 is a clinical study titled "Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain". The aims of this proposal are to (1) examine the feasibility of providing a training course of Auricular Point Acupressure (APA) for clinical oncology nurses who can integrate APA into real-world nursing care settings and (2) examine the effectiveness of APA on cancer-related pain (CRP) under the us...

What is the current status of trial NCT04040140?

This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2019-10-08. Estimated completion is 2021-01-30.

What interventions are being tested in trial NCT04040140?

The interventions under investigation include: APA Treatment (OTHER).

Who is sponsoring clinical trial NCT04040140?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04040140's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04040140, the US trial registry maintained by the National Library of Medicine. NCT04040140 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.